H. Soda

Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study

J. Sakamoto, Takao Takahashi, S. Hazama, 2015, BMC Cancer.

The Longitudinal Effects of the “Green Revolution” on the Infant Mortality Rate in Rural Thailand

Y. Ishida, M. Nonaka, T. Hatakeyama, 2006 .

Case Report of a Patient with a Favorable Prognosis Following Excision of a Metastatic Inguinal Sac Tumor Originating from Cecum Cancer

T. Midorikawa, Y. Sanada, T. Hatakeyama, 2005 .

A Case of Pneumothorax in Which Progression of Reexpansion Pulmonary Edema Was Arrested

Y. Ishida, M. Nonaka, O. Sakurai, 2006 .